Logo image of CCL-B.CA

CCL INDUSTRIES INC - CL B (CCL-B.CA) Stock Fundamental Analysis

TSX:CCL-B - Toronto Stock Exchange - CA1249003098 - Common Stock - Currency: CAD

68.35  -0.25 (-0.36%)

Fundamental Rating

6

Taking everything into account, CCL-B scores 6 out of 10 in our fundamental rating. CCL-B was compared to 8 industry peers in the Containers & Packaging industry. While CCL-B has a great profitability rating, there are some minor concerns on its financial health. CCL-B is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CCL-B had positive earnings in the past year.
CCL-B had a positive operating cash flow in the past year.
Each year in the past 5 years CCL-B has been profitable.
CCL-B had a positive operating cash flow in each of the past 5 years.
CCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 8.55%, CCL-B is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
CCL-B has a better Return On Equity (15.97%) than 87.50% of its industry peers.
CCL-B has a Return On Invested Capital of 9.60%. This is in the better half of the industry: CCL-B outperforms 75.00% of its industry peers.
CCL-B had an Average Return On Invested Capital over the past 3 years of 9.32%. This is in line with the industry average of 8.86%.
The 3 year average ROIC (9.32%) for CCL-B is below the current ROIC(9.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.55%
ROE 15.97%
ROIC 9.6%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
CCL-B.CA Yearly ROA, ROE, ROICCCL-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CCL-B has a Profit Margin of 11.64%. This is amongst the best in the industry. CCL-B outperforms 87.50% of its industry peers.
CCL-B's Profit Margin has improved in the last couple of years.
CCL-B's Operating Margin of 14.70% is amongst the best of the industry. CCL-B outperforms 87.50% of its industry peers.
CCL-B's Operating Margin has been stable in the last couple of years.
CCL-B has a Gross Margin (29.51%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CCL-B has remained more or less at the same level.
Industry RankSector Rank
OM 14.7%
PM (TTM) 11.64%
GM 29.51%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
CCL-B.CA Yearly Profit, Operating, Gross MarginsCCL-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCL-B is still creating some value.
The number of shares outstanding for CCL-B has been reduced compared to 1 year ago.
CCL-B has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCL-B has an improved debt to assets ratio.
CCL-B.CA Yearly Shares OutstandingCCL-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CCL-B.CA Yearly Total Debt VS Total AssetsCCL-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

CCL-B has an Altman-Z score of 3.49. This indicates that CCL-B is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.49, CCL-B is doing good in the industry, outperforming 62.50% of the companies in the same industry.
The Debt to FCF ratio of CCL-B is 4.07, which is a neutral value as it means it would take CCL-B, 4.07 years of fcf income to pay off all of its debts.
CCL-B has a Debt to FCF ratio of 4.07. This is in the lower half of the industry: CCL-B underperforms 62.50% of its industry peers.
CCL-B has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, CCL-B is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.07
Altman-Z 3.49
ROIC/WACC1.43
WACC6.69%
CCL-B.CA Yearly LT Debt VS Equity VS FCFCCL-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

CCL-B has a Current Ratio of 2.01. This indicates that CCL-B is financially healthy and has no problem in meeting its short term obligations.
CCL-B has a Current ratio of 2.01. This is in the better half of the industry: CCL-B outperforms 62.50% of its industry peers.
CCL-B has a Quick Ratio of 1.47. This is a normal value and indicates that CCL-B is financially healthy and should not expect problems in meeting its short term obligations.
CCL-B's Quick ratio of 1.47 is fine compared to the rest of the industry. CCL-B outperforms 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.01
Quick Ratio 1.47
CCL-B.CA Yearly Current Assets VS Current LiabilitesCCL-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.67% over the past year.
CCL-B shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.99% yearly.
The Revenue has grown by 8.95% in the past year. This is quite good.
The Revenue has been growing slightly by 6.37% on average over the past years.
EPS 1Y (TTM)34.67%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%36.49%
Revenue 1Y (TTM)8.95%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%9.02%

3.2 Future

CCL-B is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.26% yearly.
Based on estimates for the next years, CCL-B will show a small growth in Revenue. The Revenue will grow by 4.39% on average per year.
EPS Next Y-0.82%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
EPS Next 5YN/A
Revenue Next Year5.25%
Revenue Next 2Y4.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCL-B.CA Yearly Revenue VS EstimatesCCL-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
CCL-B.CA Yearly EPS VS EstimatesCCL-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

CCL-B is valuated correctly with a Price/Earnings ratio of 14.54.
62.50% of the companies in the same industry are cheaper than CCL-B, based on the Price/Earnings ratio.
CCL-B is valuated rather cheaply when we compare the Price/Earnings ratio to 28.64, which is the current average of the S&P500 Index.
CCL-B is valuated correctly with a Price/Forward Earnings ratio of 14.66.
Based on the Price/Forward Earnings ratio, CCL-B is valued a bit more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CCL-B to the average of the S&P500 Index (21.44), we can say CCL-B is valued slightly cheaper.
Industry RankSector Rank
PE 14.54
Fwd PE 14.66
CCL-B.CA Price Earnings VS Forward Price EarningsCCL-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CCL-B's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. CCL-B is more expensive than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CCL-B is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 19.94
EV/EBITDA 9.1
CCL-B.CA Per share dataCCL-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The excellent profitability rating of CCL-B may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.32
EPS Next 2Y2.88%
EPS Next 3Y8.26%

5

5. Dividend

5.1 Amount

CCL-B has a Yearly Dividend Yield of 1.87%. Purely for dividend investing, there may be better candidates out there.
CCL-B's Dividend Yield is comparable with the industry average which is at 3.56.
CCL-B's Dividend Yield is slightly below the S&P500 average, which is at 2.52.
Industry RankSector Rank
Dividend Yield 1.87%

5.2 History

The dividend of CCL-B is nicely growing with an annual growth rate of 11.36%!
CCL-B has paid a dividend for at least 10 years, which is a reliable track record.
CCL-B has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.36%
Div Incr Years23
Div Non Decr Years34
CCL-B.CA Yearly Dividends per shareCCL-B.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

24.48% of the earnings are spent on dividend by CCL-B. This is a low number and sustainable payout ratio.
The dividend of CCL-B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP24.48%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
CCL-B.CA Yearly Income VS Free CF VS DividendCCL-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CCL-B.CA Dividend Payout.CCL-B.CA Dividend Payout, showing the Payout Ratio.CCL-B.CA Dividend Payout.PayoutRetained Earnings

CCL INDUSTRIES INC - CL B

TSX:CCL-B (4/23/2025, 7:00:00 PM)

68.35

-0.25 (-0.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)02-19 2025-02-19/amc
Earnings (Next)05-07 2025-05-07
Inst Owners40.46%
Inst Owner ChangeN/A
Ins Owners3.79%
Ins Owner ChangeN/A
Market Cap12.00B
Analysts82.11
Price Target92.62 (35.51%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.87%
Yearly Dividend1.16
Dividend Growth(5Y)11.36%
DP24.48%
Div Incr Years23
Div Non Decr Years34
Ex-Date03-17 2025-03-17 (0.32)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.43%
Min EPS beat(2)-5.47%
Max EPS beat(2)-1.39%
EPS beat(4)2
Avg EPS beat(4)10.68%
Min EPS beat(4)-5.47%
Max EPS beat(4)46.26%
EPS beat(8)3
Avg EPS beat(8)2.84%
EPS beat(12)5
Avg EPS beat(12)2.21%
EPS beat(16)8
Avg EPS beat(16)2.56%
Revenue beat(2)0
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)1.57%
Revenue beat(8)1
Avg Revenue beat(8)-1.9%
Revenue beat(12)3
Avg Revenue beat(12)-1.63%
Revenue beat(16)6
Avg Revenue beat(16)-1.16%
PT rev (1m)0%
PT rev (3m)1.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.83%
EPS NY rev (1m)-0.54%
EPS NY rev (3m)-0.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.99%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.71%
Valuation
Industry RankSector Rank
PE 14.54
Fwd PE 14.66
P/S 1.66
P/FCF 19.94
P/OCF 11.28
P/B 2.27
P/tB 7.42
EV/EBITDA 9.1
EPS(TTM)4.7
EY6.88%
EPS(NY)4.66
Fwd EY6.82%
FCF(TTM)3.43
FCFY5.01%
OCF(TTM)6.06
OCFY8.86%
SpS41.25
BVpS30.07
TBVpS9.21
PEG (NY)N/A
PEG (5Y)1.32
Profitability
Industry RankSector Rank
ROA 8.55%
ROE 15.97%
ROCE 12.75%
ROIC 9.6%
ROICexc 10.66%
ROICexgc 20.78%
OM 14.7%
PM (TTM) 11.64%
GM 29.51%
FCFM 8.31%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
ROICexc(3y)10.42%
ROICexc(5y)10.66%
ROICexgc(3y)20.67%
ROICexgc(5y)21.9%
ROCE(3y)12.39%
ROCE(5y)12.67%
ROICexcg growth 3Y-4.22%
ROICexcg growth 5Y-2.39%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-0.08%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
F-Score8
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.07
Debt/EBITDA 1.6
Cap/Depr 106.85%
Cap/Sales 6.38%
Interest Coverage 18.55
Cash Conversion 71.06%
Profit Quality 71.39%
Current Ratio 2.01
Quick Ratio 1.47
Altman-Z 3.49
F-Score8
WACC6.69%
ROIC/WACC1.43
Cap/Depr(3y)114.57%
Cap/Depr(5y)103.99%
Cap/Sales(3y)6.78%
Cap/Sales(5y)6.27%
Profit Quality(3y)87.06%
Profit Quality(5y)92.08%
High Growth Momentum
Growth
EPS 1Y (TTM)34.67%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%36.49%
EPS Next Y-0.82%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
EPS Next 5YN/A
Revenue 1Y (TTM)8.95%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%9.02%
Revenue Next Year5.25%
Revenue Next 2Y4.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.63%
EBIT growth 3Y8.62%
EBIT growth 5Y7.62%
EBIT Next Year39.6%
EBIT Next 3Y15.78%
EBIT Next 5YN/A
FCF growth 1Y11.11%
FCF growth 3Y5.34%
FCF growth 5Y6.76%
OCF growth 1Y6.04%
OCF growth 3Y8.25%
OCF growth 5Y6.42%